A decrease of KCC2 expression was observed in the hippocampus of mice engineered to express recombinant neutralizing anti-nerve growth factor (NGF) antibodies (AD11 mice), which develop an age-dependent neurodegenerative pathology reminiscent of that observed in AD patients ([60]; Figure 1). This evidence concerns the gene SLC12A5 and Alzheimer disease.